中文 / EN
News

News

新闻中心

2024-08
-02

Capping Agent LZCap® Completes FDA Registration, Accelerating Global mRNA Development

View Details
Capping Agent LZCap® Completes FDA Registration, Accelerating Global mRNA Development
2024-06
-24

Cell Reports：LZCap® Capped Multivalent mRNA Vaccine Study Shows 100% Immune Protection-1

View Details
Cell Reports：LZCap® Capped Multivalent mRNA Vaccine Study Shows 100% Immune Protection-1
2024-04
-28

Henovcom Is Invited to Give an Oral Presentation at TIDES USA

View Details
Henovcom Is Invited to Give an Oral Presentation at TIDES USA
2023-07
-19

3rd mRNA Based Therapeutics Summit USA

View Details
3rd mRNA Based Therapeutics Summit USA
2023-05
-30

【Reprint】AI, mRNA vaccine...experts eye latest biomedicine trends in GZ

View Details
【Reprint】AI, mRNA vaccine...experts eye latest biomedicine trends in GZ
2023-05
-23

Breakthrough in patent lockdown! Henovcom's self-developed mRNA cap analogues have been patented for protection

View Details
Breakthrough in patent lockdown! Henovcom's self-developed mRNA cap analogues have been patented for protection
12